Bisphosphonate News and Research

RSS
Bisphosphonate is a drug or substance used to treat hypercalcemia (abnormally high blood calcium) and bone pain caused by some types of cancer. Forms of bisphosphonates are also used to treat osteoporosis and for bone imaging. Bisphosphonates inhibit a type of bone cell that breaks down bone. Also called diphosphonate.
Study identifies link between hip fracture risk and nanoscale bone inflexibility

Study identifies link between hip fracture risk and nanoscale bone inflexibility

Prolonged use of bisphosphonates increases risk of atypical femur fractures

Prolonged use of bisphosphonates increases risk of atypical femur fractures

Bisphosphonates may be safe and beneficial for osteoarthritis patients

Bisphosphonates may be safe and beneficial for osteoarthritis patients

Researchers examine the implications of bisphosphonate drug holidays on fracture risk

Researchers examine the implications of bisphosphonate drug holidays on fracture risk

New guidance released for treating patients with osteoporosis during COVID-19 crisis

New guidance released for treating patients with osteoporosis during COVID-19 crisis

Osteoporosis drugs associated with reduced risk of premature mortality

Osteoporosis drugs associated with reduced risk of premature mortality

Benefits of osteoporosis treatment in postmenopausal women outweigh the perceived risks

Benefits of osteoporosis treatment in postmenopausal women outweigh the perceived risks

Bisphosphonates to treat osteoporosis appears to be beneficial for all women

Bisphosphonates to treat osteoporosis appears to be beneficial for all women

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Microscopic imaging helps better understand cancer bone metastasis

Microscopic imaging helps better understand cancer bone metastasis

Study finds incidence of fractures in 15% of osteoporosis patients who take 'drug holidays'

Study finds incidence of fractures in 15% of osteoporosis patients who take 'drug holidays'

New treatment option appears promising for patients with glucocorticoid-induced osteoporosis

New treatment option appears promising for patients with glucocorticoid-induced osteoporosis

Researchers find potential remedy that could restore hearing for millions

Researchers find potential remedy that could restore hearing for millions

Scientists reveal novel approach to restoration of hearing

Scientists reveal novel approach to restoration of hearing

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Comprehensive surgical options could benefit osteoporosis patients with medication-related jaw necrosis

Comprehensive surgical options could benefit osteoporosis patients with medication-related jaw necrosis

New therapeutic approach offers hope for individuals with debilitating bone cancer

New therapeutic approach offers hope for individuals with debilitating bone cancer

ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

ACR’s updated guideline provides recommendations on treatment of glucocorticoid-induced osteoporosis

Study finds higher risk of fractures among older, long-term bisphosphonate users

Study finds higher risk of fractures among older, long-term bisphosphonate users

New mutation predisposes patients under osteoporosis treatment to atypical femur fractures, study finds

New mutation predisposes patients under osteoporosis treatment to atypical femur fractures, study finds